Related Experiment Video
Updated: Mar 23, 2026

06:01
Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
7.2K
Abnormal miRNA-30e Expression is Associated with Breast Cancer Progression
Clinical Laboratory
|March 26, 2016
Summary
Reduced miR-30e expression correlates with advanced breast cancer stage. Further research may reveal miR-30e's potential as a breast cancer therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) regulate cellular processes and are implicated in cancer.
- miRNAs play crucial roles in cell differentiation, proliferation, metabolism, and apoptosis.
Purpose of the Study:
- To investigate the role of microRNAs in breast cancer progression.
- To analyze miRNA expression profiles in plasma and tissues of breast cancer patients.
Main Methods:
- TaqMan-based miRNA profiling was performed on plasma samples from breast cancer patients, patients with unrelated diseases, and healthy controls.
- miRNA expression was also analyzed in breast tumors and adjacent non-tumors.
- Statistical analyses and receiver-operating characteristic (ROC) curve analyses were conducted.
Main Results:
- let-7i, let-7a, and miR-650 were significantly upregulated in plasma.
- miR-21 was upregulated in breast cancer tissue, while miR-30e was downregulated in both plasma and tissues.
- Plasma miR-30e expression correlated with patient age and clinical stage, but could not significantly differentiate breast cancer from controls via ROC analysis.
Conclusions:
- Reduced miR-30e expression is associated with the clinical stage of breast cancer.
- miR-30e may function as a tumor suppressor in breast cancer.
- Further investigation into miR-30e's therapeutic potential is warranted.
Related Concept Videos
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs
24.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

